- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07572058
Large Diameter ViSiGi LUX ™ Gastric Sizing and Calibration System
May 12, 2026 updated by: Boehringer Labs LLC
Large Diameter ViSiGi LUX ™ Gastric Sizing and Calibration System Usability Study
This study investigates the use of the large diameter ViSiGi LUX ™
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Barrett Genovese
- Phone Number: 4849312294
- Email: bgenovese@boehringerlabs.com
Study Locations
-
-
California
-
Rancho Mirage, California, United States, 92270
- Eisenhower Medical Center
-
Contact:
- Lainie Hughes
- Phone Number: 760-837-8237
- Email: lhughes@eisenhowerhealth.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18 years or older
- Able to consent
- Candidate for laparoscopic gastric surgery
Exclusion Criteria:
- Esophageal stricture that does not allow passage of the device
- Conditions that would preclude gastric surgical procedures
- Pregnant patients
- Non-English-speaking patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Large Diameter ViSiGi LUX ™
|
ViSiGi LUX ™ is used during numerous gastric procedures.
This new device functions the same as ViSiGi LUX ™ but has an increased diameter representative of existing devices used more frequently in upper gastric procedures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Technical success rate
Time Frame: 6 months
|
Successful introduction of the sizing and calibration system, correct positioning and function intraoperatively will be logged following each use of the device.
This will be assessed by the operating physician.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 19, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
April 22, 2026
First Submitted That Met QC Criteria
May 4, 2026
First Posted (Actual)
May 7, 2026
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 12, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- LDL-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Surgery
-
Jeffrey HazeyCompleted
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnGastric Bypass Surgery
-
Cairo UniversityRecruiting
-
RSP Systems A/SCompleted
-
Vrinnevi HospitalActive, not recruitingRevisional Bariatric Surgery | Gastric Bypass Surgery | Complications After Bariatric SurgerySweden
-
Mayo ClinicCompletedRoux-en-Y Gastric Bypass | Gastric Bypass | Bariatric SurgeryUnited States
-
Rijnstate HospitalCompletedRoux-en-Y Gastric Bypass | Gastric Emptying | Bariatric SurgeryNetherlands
-
CARLOS ZERRWECK LOPEZCompletedRoux-en-Y Gastric Bypass | Bariatric Surgery | Metabolic SurgeryMexico
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedRoux-en-Y Gastric Bypass | Bariatric Surgery | Vertical Sleeve Gastrectomy | Gastric Banding | Bypass, GastricUnited States
-
Cantonal Hospital of St. GallenCompletedBariatric Surgery (Gastric Bypass)Switzerland
Clinical Trials on Large Diameter ViSiGi LUX ™
-
Atrium Medical CorporationCompletedCoarctation of the AortaIsrael, Australia, Brazil, Canada, Germany, Italy, United Kingdom
-
University of British ColumbiaUnknown
-
Boston Children's HospitalCompletedUniventricular HeartUnited States
-
National Taiwan University HospitalUnknownKeratoconus | Ocular Surface Disease | Irregular AstigmatismTaiwan
-
CorinTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis
-
University of California, San FranciscoCompleted
-
Mayo ClinicStryker NordicCompletedGlenohumeral Joint DegenerationUnited States
-
Taipei Medical University HospitalUnknown
-
Lashmi VenkatraghavanUniversity Health Network, TorontoCompletedElevated Intracranial Pressure (ICP)Canada
-
Biomet Orthopedics, LLCWithdrawnArthritis | Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis